Guiding blood pressure medicine reduction in septic shock
Part of Infections clinical trials.
This study looks at a new way to guide how safely doctors can reduce the strong blood pressure medicine (norepinephrine) in ICU patients with septic shock. Participants must be on a ventilator and have stable blood pressure and heart function.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 or older.
- You are in the ICU with septic shock (a life-threatening infection causing low blood pressure).
- You need a breathing machine (ventilator).
- You have been on a blood-pressure-raising drug (norepinephrine) for at least 4 hours.
- Your condition is stable enough that doctors can start lowering the drug, with blood pressure above 75 mmHg, good heart function, and low lactate levels.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests different combinations of blood pressure medicines given to patients on a breathing machine who have septic shock. The goal is to find the best dose of a second medicine when norepinephrine alone isn't enough.
This trial tests whether different blood pressure medicines protect kidney function better in people with septic shock (a severe infection that causes low blood pressure). It compares norepinephrine (the standard treatment) with other options to see which is best for the kidneys.
This trial tests whether giving a medicine called norepinephrine early and adjusting the dose quickly can help people with sepsis who have very low blood pressure. It is for adults who are diagnosed within the last 3 hours and who have not already received this medicine.
This trial studies how norepinephrine affects the heart and circulation in adults with septic shock whose blood pressure stays low after the first day. It may help doctors better choose and adjust medicines to support blood pressure and organ function.
This study tests two blood pressure-raising medicines, norepinephrine and angiotensin-II, in people with septic shock. It aims to see which one works better to improve blood flow and oxygen delivery to organs.
This trial examines how the renin-angiotensin-aldosterone system (a hormone system that helps control blood pressure) changes in patients with septic shock, compared to those with sepsis without shock, cardiogenic shock, and healthy volunteers. The goal is to better understand these changes and possibly improve treatment.
Hear when a new Septic Shock trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.